Back to Search

DOUGLAS W MAPEL MD

MD

Critical Care Medicine (Internal Medicine) Physician

NPI: 1497730451IndividualAccepts Medicare

Specialties, Licenses & Credentials

Pulmonary Disease Physician

Internal Medicine — Pulmonary Disease

Code: 207RP1001X

30994(AZ)
Internal Medicine Physician

Internal Medicine

Code: 207R00000X

30994(AZ)
Critical Care Medicine (Internal Medicine) PhysicianPrimary

Internal Medicine — Critical Care Medicine

Code: 207RC0200X

30994(AZ)

Education

UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON

Class of 1988

Research & Publications (20)

Cost-effectiveness of fluticasone propionate/salmeterol (500/50 microg) in the treatment of COPD.
PMID 19010652·Respir Med·2009
8-other
A comparison of health-care costs in patients with chronic obstructive pulmonary disease using lightweight portable oxygen systems versus traditional compressed-oxygen systems.
PMID 18718034·Respir Care·2008
4-observational
COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.
PMID 18671149·COPD·2008
6-review
Burden of concomitant asthma and COPD in a Medicaid population.
PMID 18339789·Chest·2008
8-other
Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
PMID 17530506·COPD·2007
4-observational
The natural history of chronic obstructive pulmonary disease.
PMID 16507865·Eur Respir J·2006
6-review
Estimating the cost of COPD--a matter of perspective.
PMID 17361497·COPD·2006
8-other
Recommendations of the 6th long-term oxygen therapy consensus conference.
PMID 16710952·Respir Care·2006
8-other
Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists.
PMID 16199151·Respir Med·2006
8-other
Predicting the costs of managing patients with chronic obstructive pulmonary disease.
PMID 16140232·Respir Med·2005
2-rct
Economic evaluation of treating chronic obstructive pulmonary disease with inhaled corticosteroids and long-acting beta2-agonists in a health maintenance organization.
PMID 16291076·Respir Med·2005
8-other
Trends and cardiovascular co-morbidities of COPD patients in the Veterans Administration Medical System, 1991-1999.
PMID 17136959·COPD·2005
8-other
Treatment implications on morbidity and mortality in COPD.
PMID 15302775·Chest·2004
6-review
The cost of chronic obstructive pulmonary disease and its effects on managed care.
PMID 15108761·Manag Care Interface·2004
4-observational
Hospital, pharmacy, and outpatient costs for osteoarthritis and chronic back pain.
PMID 14994407·J Rheumatol·2004
8-other
Undiagnosed airflow obstruction: prevalence and implications.
PMID 12574688·Curr Opin Pulm Med·2003
6-review
The pharmacoepidemiology of COPD: recent advances and methodological discussion.
PMID 14582902·Eur Respir J Suppl·2003
6-review
Obtaining evidence for use by healthcare payers on the success of chronic obstructive pulmonary disease management.
PMID 12199488·Respir Med·2002
6-review
A 47-year-old woman with wheezing and respiratory failure unresponsive to conventional ventilatory modalities.
PMID 12006462·Chest·2002
5-case
The health impact of undiagnosed airflow obstruction in a national sample of United States adults.
PMID 11500335·Am J Respir Crit Care Med·2001
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via NORTHERN ARIZONA PULMONARY ASSOCIATES, LLC · 3 locations total

Address
1360 N RIM DR
FLAGSTAFF, AZ 86001
Practice locations map

Locations (3)

NORTHERN ARIZONA PULMONARY ASSOCIATES, LLC

1360 N RIM DR, FLAGSTAFF, AZ
(928) 774-8000

CRITICAL CARE CONSULTANTS OF ARIZONA PLLC

1003 WILLOW CREEK RD, PRESCOTT, AZ
(928) 773-0003

Practice Location

7700 E Florentine Rd, Prescott Valley, AZ
(928) 773-0003

Quick Facts

NPI
1497730451
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
3
Locations
3
Years in Practice
38
Publications
20

Are you this provider?

Claim Your Profile